The Impact of Dietary Habits and Nutrition Intervention on Metabolic Syndrome in Individuals With Schizophrenia
NCT04025073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2019-07-18
Summary
Metabolic syndrome is a term used to describe a complex clinical condition that includes abdominal obesity, increased level of serum triglycerides, elevated blood pressure, decreased level of high-density lipoprotein cholesterol, and high fasting glucose level. Metabolic syndrome represents one of the major risk factors for the development of cardiovascular diseases and type 2 diabetes mellitus. According to the results of numerous previously conducted studies, the prevalence of metabolic syndrome among the individuals with schizophrenia is higher than in the general population.
The reasons for the higher prevalence of metabolic syndrome among the individuals with schizophrenia are not yet fully clarified. Nevertheless, unhealthy dietary habits are considered to be one of the main factors that could have an impact on metabolic syndrome development. According to the results of published studies, individuals with schizophrenia have poorer dietary habits when compared to people without mental disorders.
Although there are numerous previously published studies focused on the impact of nutritional interventions on metabolic syndrome in individuals with schizophrenia, there is still no consensus on what would be the most appropriate nutrition therapy for the treatment of metabolic syndrome in this specific population group. Furthermore, the vast majority of the published studies have been conducted on outpatients, with only a small number of them being carried out on hospitalized individuals with a diagnosis of schizophrenia.
Dietary Approaches to Stop Hypertension (DASH) diet is primarily intended to those individuals with elevated blood pressure, but according to some authors, it could have beneficial effects in the treatment of the metabolic syndrome as well. DASH diet represents a healthy way of eating with a special emphasis on low-fat dairy products, fruits, vegetables and whole grains, together with an overall reduction in sodium intake.
Therefore, the present study aims to determine the impact of dietary habits and nutrition intervention on metabolic syndrome parameters in hospitalized individuals with the diagnosis of schizophrenia.
The investigators hypothesize that the intervention will result in the improvement in metabolic syndrome parameters, the amelioration in dietary habits, and the reduction in body weight.
Conditions
- Metabolic Syndrome
Interventions
- OTHER
-
Dietary Approaches to Stop Hypertension
The DASH diet will have a reduced caloric intake by 400 kcal/day, when compared to the standard hospital diet. The DASH diet will be planned according to the following: total daily energy intake 1,900 kcal; total daily fat intake 27%; daily intake of saturated fatty acids 6%; total daily protein intake 18%; total daily carbohydrates intake 55%; cholesterol 150 mg/day; sodium 2,300 mg/day; potassium 4,700 mg/day; calcium 1,250 mg/day; magnesium 500 mg/day; and fiber 30 g/day.
- OTHER
-
Nutrition education program
The nutrition education program will consist of four lectures intended to improve the overall participants' dietary habits. The lectures will be interactive and will be organized in smaller groups (up to 10 participants) covering the following themes: My Plate dietary guidelines; Principles of a balanced diet; Reading and understanding food nutrition labels; Dietary recommendations for elevated blood pressure, dyslipidemia, and diabetes mellitus.
Sponsors & Collaborators
-
University of Zagreb
collaborator OTHER -
Tamara Sorić
lead INDIV
Principal Investigators
-
Tamara Sorić, MSc · Psychiatric Hospital Ugljan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 67 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-02
- Primary Completion
- 2017-12-20
- Completion
- 2017-12-20
Countries
- Croatia
Study Locations
More Related Trials
-
Ketogenic Diet in People With Schizophrenia
NCT05968638 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of Social Cognition Training in Schizophrenia
NCT00587561 ·Status: COMPLETED ·Phase: NA
-
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
NCT00501163 ·Status: COMPLETED
-
Acute Effects of Exercise in Smokers With Schizophrenia
NCT01635075 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia
NCT07141966 ·Status: COMPLETED
-
Neuronal Effects of Exercise in Schizophrenia
NCT02455193 ·Status: RECRUITING ·Phase: NA
-
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
NCT04518319 ·Status: SUSPENDED ·Phase: PHASE2
-
Somatic Comorbidities in Psychiatric Patients
NCT02773108 ·Status: COMPLETED
-
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NCT04027634 ·Status: COMPLETED ·Phase: NA
-
Factors Association With Poor Physical Function in Older Adults With Schizophrenia
NCT01092598 ·Status: COMPLETED
-
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness
NCT03627377 ·Status: UNKNOWN ·Phase: NA
-
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
NCT00455702 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Social Skills Intervention on Praxis and Social Functioning in Individuals With Schizophrenia
NCT05901922 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
NCT06197048 ·Status: RECRUITING ·Phase: NA
-
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia
NCT03699501 ·Status: COMPLETED
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cognitive Training for Patients With Schizophrenia
NCT01521026 ·Status: COMPLETED ·Phase: NA
-
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
NCT00569504 ·Status: UNKNOWN
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
NCT01477918 ·Status: UNKNOWN
-
Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial
NCT06572657 ·Status: COMPLETED ·Phase: NA
-
Clinical Symptoms of Schizophrenia and Physical Exercise
NCT01674543 ·Status: COMPLETED ·Phase: NA
-
Generalization of Training in Schizophrenia
NCT00108199 ·Status: COMPLETED ·Phase: NA
-
Improving Cognition Via Exercise in Schizophrenia
NCT03270098 ·Status: COMPLETED ·Phase: NA
-
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia
NCT01915017 ·Status: COMPLETED ·Phase: NA